{"cursor":"12572","size":15,"audio":[],"currentlang":"en","article":"'Humanized antibodies' are antibodies from non-human species whose protein\nsequences have been modified to increase their similarity to antibody variants\nproduced naturally in humans. (This is an\nearly example of the use of the term \"humanized antibody\".) The process of\n\"humanization\" is usually applied to monoclonal antibodies developed for\nadministration to humans (for example, antibodies developed as anti-cancer\ndrugs). Humanization can be necessary when the process of developing a specific\nantibody involves generation in a non-human immune system (such as that in\nmice). The protein sequences of antibodies produced in this way are partially\ndistinct from homologous antibodies occurring naturally in humans, and are\ntherefore potentially immunogenic when administered to human patients (see also\nHuman anti-mouse antibody). Not all monoclonal antibodies designed for human\nadministration need be humanized since many therapies are short-term\ninterventions (see List of monoclonal antibodies to get an overview of the\nvarious types of antibodies developed for therapeutic administration in humans).\nThe International Nonproprietary Names of humanized antibodies end in -zumab, as\nin [[omalizumab]] (see Nomenclature of monoclonal antibodies).\n\nHumanized antibodies are distinct from chimeric antibodies. The latter also have\ntheir protein sequences made more similar to human antibodies, but carry a\nlarger stretch of non-human protein.\n","linknr":570,"url":"humanized","recorded":1363437478,"links":["/w/index.php?title=Humanized_antibody&action=edit","/w/index.php?title=Humanized_antibody&action=edit","//en.wikipedia.org/apple-touch-icon.png","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","/wiki/Humanized_antibody","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","/w/index.php?title=Humanized&redirect=no","#mw-head","#p-search","/wiki/Antibodies","/wiki/Peptide_sequence","#cite_note-pmid3127726-1","#cite_note-2","/wiki/Monoclonal_antibody","/wiki/Antibody_generator","/wiki/Homology_(biology)","/wiki/Immunogenic","/wiki/Human_anti-mouse_antibody","/wiki/List_of_monoclonal_antibodies","/wiki/International_Nonproprietary_Name","/wiki/Omalizumab","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/Chimeric_antibodies","#Use_of_recombinant_DNA_in_humanization_process","#Distinction_from_.22chimeric_antibody.22","#Humanizing_via_a_chimeric_intermediate","#Humanization_by_insertion_of_relevant_CDRs_into_human_antibody_.22scaffold.22","#Antibodies_for_human_therapy_derived_without_using_mice","#Display_methods","#Antibodies_from_human_patients_or_vaccine_recipients","#References","#See_also","/w/index.php?title=Humanized_antibody&action=edit&section=1","/wiki/Recombinant_DNA","/wiki/Expression_vector","#cite_note-pmid9202712-3","/wiki/Gene_expression","/wiki/Mammal","/wiki/Cell_culture","/wiki/Molecular_cloning","/wiki/Bioreactor","/wiki/Proteins","/wiki/Phage_display","/w/index.php?title=Humanized_antibody&action=edit&section=2","/wiki/File:Chimeric_and_humanized_antibodies.svg","//upload.wikimedia.org/wikipedia/commons/thumb/4/44/Chimeric_and_humanized_antibodies.svg/200px-Chimeric_and_humanized_antibodies.svg.png","/wiki/File:Chimeric_and_humanized_antibodies.svg","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/magnify-clip.png","/wiki/Chimeric_antibody","/wiki/Fusion_protein","/wiki/Fragment_crystallizable_region","/wiki/Complementarity_determining_region","/wiki/Abciximab","/wiki/Basiliximab","/wiki/Cetuximab","/wiki/Infliximab","/wiki/Rituximab","/wiki/Bavituximab","/wiki/List_of_monoclonal_antibodies","/w/index.php?title=Humanized_antibody&action=edit&section=3","/wiki/Fragment_antigen-binding","/wiki/Mutagenesis","/wiki/Otelixizumab","/wiki/Rheumatoid_arthritis","/wiki/Diabetes_mellitus","#cite_note-4","/w/index.php?title=Humanized_antibody&action=edit&section=4","#cite_note-pmid9202712-3","/wiki/DNA_sequencing","#cite_note-pmid15848072-5","#cite_note-pmid18424812-6","/wiki/Gene_synthesis","/wiki/Alemtuzumab","/wiki/CD52","#cite_note-pmid3127726-1","#cite_note-7","/wiki/Multiple_sclerosis","#cite_note-8","/w/index.php?title=Humanized_antibody&action=edit&section=5","/wiki/Phage_display","/w/index.php?title=Humanized_antibody&action=edit&section=6","/wiki/Phage_display","/wiki/Ribosome_display","/wiki/Genomic_library","/wiki/Peripheral_blood","/wiki/Fragment_antigen-binding","/wiki/Single-chain_variable_fragment","/wiki/Adalimumab","#cite_note-pmid10577977-9","#cite_note-pmid12379628-10","/w/index.php?title=Humanized_antibody&action=edit&section=7","/wiki/Passive_immunity","#cite_note-pmid14659916-11","#cite_note-12","/w/index.php?title=Humanized_antibody&action=edit&section=8","#cite_ref-pmid3127726_1-0","#cite_ref-pmid3127726_1-1","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2F332323a0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/3127726","#cite_ref-2","//www.ncbi.nlm.nih.gov/pmc/articles/PMC298637/","/wiki/Digital_object_identifier","http://dx.doi.org/10.1073%2Fpnas.86.24.10029","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC298637","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/2513570","#cite_ref-pmid9202712_3-0","#cite_ref-pmid9202712_3-1","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0022-1759%2897%2900034-3","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9202712","#cite_ref-4","http://clinicaltrials.gov/ct2/results?term=otelixizumab","#cite_ref-pmid15848072_5-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.ymeth.2005.01.003","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15848072","#cite_ref-pmid18424812_6-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1093%2Fjb%2Fmvn052","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18424812","#cite_ref-7","http://drugbank.ca/drugs/DB00087","#cite_ref-8","http://clinicaltrials.gov/ct2/results?term=Alemtuzumab","#cite_ref-pmid10577977_9-0","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766582/","/wiki/Digital_object_identifier","http://dx.doi.org/10.1136%2Fard.58.2008.i70","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766582","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10577977","#cite_ref-pmid12379628_10-0","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766697/","/wiki/Digital_object_identifier","http://dx.doi.org/10.1136%2Fard.61.suppl_2.ii70","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766697","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12379628","#cite_ref-pmid14659916_11-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.jim.2003.09.015","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/14659916","#cite_ref-12","http://www.theraclone-sciences.com/pdf/Theraclone_ISTAR.pdf","/w/index.php?title=Humanized_antibody&action=edit&section=9","/wiki/List_of_monoclonal_antibodies","/wiki/Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems","/wiki/Template_talk:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems&action=edit","/wiki/Monoclonal","/wiki/Bone","/wiki/Denosumab","/wiki/Blosozumab","/wiki/Romosozumab","/wiki/Musculoskeletal","/wiki/Stamulumab","/wiki/Circulatory_system","/wiki/Alirocumab","/wiki/Enoticumab","/wiki/Icrucumab","/wiki/Inclacumab","/wiki/Nesvacumab","/wiki/Orticumab","/wiki/Ramucirumab","/wiki/Vesencumab","/wiki/Indium_(111In)_biciromab","/wiki/Indium_(111In)_imciromab","/wiki/Chimeric_antibody","/wiki/Abciximab","/wiki/Volociximab","/wiki/Alacizumab_pegol","/wiki/Bevacizumab","/wiki/Ranibizumab","/wiki/Caplacizumab","/wiki/Demcizumab","/wiki/Etaracizumab","/wiki/Tadocizumab","/wiki/Neurologic","/wiki/Atinumab","/wiki/Fasinumab","/wiki/Fulranumab","/wiki/Gantenerumab","/wiki/Bapineuzumab","/wiki/Crenezumab","/wiki/Ozanezumab","/wiki/Ponezumab","/wiki/Solanezumab","/wiki/Tanezumab","/wiki/Angiogenesis_inhibitor","/wiki/Ranibizumab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Monoclonals_for_immune_system","/wiki/Template_talk:Monoclonals_for_immune_system","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_immune_system&action=edit","/wiki/Monoclonal_antibodies","/wiki/Immune_system","/wiki/Immune_system","/wiki/Immunosuppression","/wiki/Adalimumab","/wiki/Atorolimumab","/wiki/Belimumab","/wiki/Brodalumab","/wiki/Carlumab","/wiki/Dupilumab","/wiki/Eldelumab","/wiki/Fresolimumab","/wiki/Golimumab","/wiki/Lerdelimumab","/wiki/Lirilumab","/wiki/Mavrilimumab","/wiki/Metelimumab","/wiki/Morolimumab","/wiki/Namilumab","/wiki/Oxelumab","/wiki/Placulumab","/wiki/Sarilumab","/wiki/Sifalimumab","/wiki/Tabalumab","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Nivolumab","/wiki/Urelumab","/wiki/Bertilimumab","/wiki/Zanolimumab","/wiki/Afelimomab","/wiki/Elsilimomab","/wiki/Faralimomab","/wiki/Gavilimomab","/wiki/Inolimomab","/wiki/Maslimomab","/wiki/Nerelimomab","/wiki/Odulimomab","/wiki/Telimomab_aritox","/wiki/Vepalimomab","/wiki/Zolimomab_aritox","/wiki/Chimeric_antibody","/wiki/Basiliximab","/wiki/Clenoliximab","/wiki/Galiximab","/wiki/Gomiliximab","/wiki/Infliximab","/wiki/Keliximab","/wiki/Lumiliximab","/wiki/Priliximab","/wiki/Teneliximab","/wiki/Vapaliximab","/wiki/Aselizumab","/wiki/Apolizumab","/wiki/Benralizumab","/wiki/Cedelizumab","/wiki/Certolizumab_pegol","/wiki/Daclizumab","/wiki/Eculizumab","/wiki/Efalizumab","/wiki/Epratuzumab","/wiki/Erlizumab","/wiki/Etrolizumab","/wiki/Fontolizumab","/wiki/Itolizumab","/wiki/Lampalizumab","/wiki/Ligelizumab","/wiki/Mepolizumab","/wiki/Mogamulizumab","/wiki/Natalizumab","/wiki/Ocrelizumab","/wiki/Omalizumab","/wiki/Ozoralizumab","/wiki/Pascolizumab","/wiki/Pateclizumab","/wiki/Pexelizumab","/wiki/Pidilizumab","/wiki/PRO_140","/wiki/Reslizumab","/wiki/Rontalizumab","/wiki/Rovelizumab","/wiki/Ruplizumab","/wiki/Quilizumab","/wiki/Samalizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Teplizumab","/wiki/Tocilizumab","/wiki/Toralizumab","/wiki/Tregalizumab","/wiki/Vatelizumab","/wiki/Vedolizumab","/wiki/Visilizumab","/wiki/TGN1412","/wiki/Ibalizumab","/wiki/Otelixizumab","/wiki/Interleukin","/wiki/Briakinumab","/wiki/Canakinumab","/wiki/Fezakinumab","/wiki/Guselkumab","/wiki/Secukinumab","/wiki/Sirukumab","/wiki/Tralokinumab","/wiki/Ustekinumab","/wiki/Anrukinzumab","/wiki/Clazakizumab","/wiki/Enokizumab","/wiki/Gevokizumab","/wiki/Ixekizumab","/wiki/Lebrikizumab","/wiki/Olokizumab","/wiki/Perakizumab","/wiki/Tildrakizumab","/wiki/Lesion","/wiki/Besilesomab","/wiki/Technetium_(99mTc)_fanolesomab","/wiki/Lemalesomab","/wiki/Technetium_(99mTc)_sulesomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","/wiki/Template:Monoclonals_for_infectious_disease_and_toxins","/wiki/Template_talk:Monoclonals_for_infectious_disease_and_toxins","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_infectious_disease_and_toxins&action=edit","/wiki/Monoclonal_antibodies","/wiki/Infectious_disease","/wiki/Toxin","/wiki/Fungal","/wiki/Efungumab","/wiki/Virus","/wiki/Exbivirumab","/wiki/Foravirumab","/wiki/Libivirumab","/wiki/Rafivirumab","/wiki/Regavirumab","/wiki/Sevirumab","/wiki/Tuvirumab","/wiki/Felvizumab","/wiki/Motavizumab","/wiki/Palivizumab","/wiki/Suvizumab","/wiki/Bacterial","/wiki/Nebacumab","/wiki/Panobacumab","/wiki/Raxibacumab","/wiki/Edobacomab","/wiki/Chimeric_antibody","/wiki/Pagibaximab","/wiki/Tefibazumab","/wiki/Toxin","/wiki/Actoxumab","/wiki/Bezlotoxumab","/wiki/Urtoxazumab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Monoclonals_for_tumors","/wiki/Template_talk:Monoclonals_for_tumors","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_tumors&action=edit","/wiki/Monoclonal_antibodies","/wiki/Tumor","/wiki/Adecatumumab","/wiki/Cixutumumab","/wiki/Conatumumab","/wiki/Daratumumab","/wiki/Drozitumab","/wiki/Duligotumab","/wiki/Dusigitumab","/wiki/Figitumumab","/wiki/Ganitumab","/wiki/Glembatumumab_vedotin","/wiki/Intetumumab","/wiki/Iratumumab","/wiki/Lexatumumab","/wiki/Lucatumumab","/wiki/Mapatumumab","/wiki/Narnatumab","/wiki/Necitumumab","/wiki/Ofatumumab","/wiki/Olaratumab","/wiki/Panitumumab","/wiki/Patritumab","/wiki/Pritumumab","/wiki/Radretumab","/wiki/Rilotumumab","/wiki/Robatumumab","/wiki/Teprotumumab","/wiki/Tovetumab","/wiki/Vantictumab","/wiki/Technetium_(99mTc)_votumumab","/wiki/Zalutumumab","/wiki/Melanoma","/wiki/Flanvotumab","/wiki/Indium_(111In)_altumomab_pentetate","/wiki/Anatumomab_mafenatox","/wiki/Technetium_(99mTc)_arcitumomab","/wiki/Bectumomab","/wiki/Blinatumomab","/wiki/Iodine_(125I)_CC49","/wiki/Detumomab","/wiki/Ibritumomab_tiuxetan","/wiki/Minretumomab","/wiki/Mitumomab","/wiki/Moxetumomab_pasudotox","/wiki/Naptumomab_estafenatox","/wiki/Technetium_(99mTc)_nofetumomab_merpentan","/wiki/Pemtumomab","/wiki/Technetium_(99mTc)_pintumomab","/wiki/Racotumomab","/wiki/Indium_(111In)_satumomab_pendetide","/wiki/Solitomab","/wiki/Taplitumomab_paptox","/wiki/Tenatumomab","/wiki/Tositumomab","/wiki/3F8","/wiki/Ovarian_tumor","/wiki/Abagovomab","/wiki/Indium_(111In)_igovomab","/wiki/Oregovomab","/wiki/Indium_(111In)_capromab_pendetide","/wiki/Edrecolomab","/wiki/Nacolomab_tafenatox","/wiki/Chimeric_antibody","/wiki/Amatuximab","/wiki/Bavituximab","/wiki/Brentuximab_vedotin","/wiki/Cetuximab","/wiki/Ensituximab","/wiki/Futuximab","/wiki/Girentuximab","/wiki/Indatuximab_ravtansine","/wiki/Margetuximab","/wiki/Rituximab","/wiki/Siltuximab","/wiki/Ublituximab","/wiki/Melanoma","/wiki/Ecromeximab","/wiki/Afutuzumab","/wiki/Alemtuzumab","/wiki/Bevacizumab","/wiki/Bivatuzumab_mertansine","/wiki/Cantuzumab_mertansine","/wiki/Cantuzumab_ravtansine","/wiki/Citatuzumab_bogatox","/wiki/Yttrium_(90Y)_clivatuzumab_tetraxetan","/wiki/Dacetuzumab","/wiki/Dalotuzumab","/wiki/Elotuzumab","/wiki/Etaracizumab","/wiki/Farletuzumab","/wiki/Ficlatuzumab","/wiki/Gemtuzumab_ozogamicin","/wiki/Imgatuzumab","/wiki/Inotuzumab_ozogamicin","/wiki/Labetuzumab","/wiki/Lintuzumab","/wiki/Lorvotuzumab_mertansine","/wiki/Matuzumab","/wiki/Milatuzumab","/wiki/Nimotuzumab","/wiki/Ocaratuzumab","/wiki/Onartuzumab","/wiki/Oportuzumab_monatox","/wiki/Parsatuzumab","/wiki/Pertuzumab","/wiki/Sibrotuzumab","/wiki/Simtuzumab","/wiki/Yttrium_(90Y)_tacatuzumab_tetraxetan","/wiki/Tigatuzumab","/wiki/Trastuzumab","/wiki/Tucotuzumab_celmoleukin","/wiki/Veltuzumab","/wiki/Vorsetuzumab_mafodotin","/wiki/Trifunctional_antibody","/wiki/Catumaxomab","/wiki/Ertumaxomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","http://en.wikipedia.org/w/index.php?title=Humanized_antibody&oldid=544320457","/wiki/Help:Categories","/wiki/Category:Monoclonal_antibodies","/w/index.php?title=Special:UserLogin&returnto=Humanized+antibody&type=signup","/w/index.php?title=Special:UserLogin&returnto=Humanized+antibody","/wiki/Humanized_antibody","/wiki/Talk:Humanized_antibody","#","/wiki/Humanized_antibody","/w/index.php?title=Humanized_antibody&action=edit","/w/index.php?title=Humanized_antibody&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Humanized_antibody","/wiki/Special:RecentChangesLinked/Humanized_antibody","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Humanized_antibody&oldid=544320457","/w/index.php?title=Humanized_antibody&action=info","/w/index.php?title=Special:Cite&page=Humanized_antibody&id=544320457","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Humanized+antibody","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Humanized+antibody&oldid=544320457&writer=rl","/w/index.php?title=Humanized_antibody&printable=yes","//he.wikipedia.org/wiki/%D7%A0%D7%95%D7%92%D7%93%D7%A0%D7%99%D7%9D_%D7%9E%D7%95%D7%90%D7%A0%D7%A9%D7%99%D7%9D","//www.wikidata.org/wiki/Special:ItemByTitle/enwiki/Humanized antibody","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//www.wikimediafoundation.org/","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","http://en.m.wikipedia.org/wiki/Humanized_antibody","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=skins.vector&only=scripts&skin=vector&*","/w/index.php?title=MediaWiki:Gadget-ReferenceTooltips.js&action=raw&ctype=text/javascript&508635914","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biology"],"pdf":["http://www.theraclone-sciences.com/pdf/Theraclone_ISTAR.pdf"],"categories":["Monoclonal antibodies"],"headings":["Use of recombinant DNA in humanization process","Distinction from \"chimeric antibody\"","Humanizing via a chimeric intermediate","Humanization by insertion of relevant CDRs into human antibody \"scaffold\"","Antibodies for human therapy derived without using mice","References","See also"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/4/44/Chimeric_and_humanized_antibodies.svg/200px-Chimeric_and_humanized_antibodies.svg.png","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/magnify-clip.png","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["homology","biology"]],"members":["homology"],"related":["Antibodies","Peptide_sequence","Monoclonal_antibody","Antibody_generator","Homology_(biology)","Immunogenic","Human_anti-mouse_antibody","List_of_monoclonal_antibodies","International_Nonproprietary_Name","Nomenclature_of_monoclonal_antibodies","Chimeric_antibodies","Recombinant_DNA","Expression_vector","Gene_expression","Mammal","Cell_culture","Molecular_cloning","Bioreactor","Proteins","Phage_display","Fusion_protein","Fragment_crystallizable_region","Complementarity_determining_region","Abciximab","Basiliximab","Cetuximab","Infliximab","Rituximab","Bavituximab","List_of_monoclonal_antibodies","Fragment_antigen-binding","Mutagenesis","Otelixizumab","Rheumatoid_arthritis","Diabetes_mellitus","DNA_sequencing","Gene_synthesis","Alemtuzumab","CD52","Multiple_sclerosis","Phage_display","Phage_display","Ribosome_display","Genomic_library","Peripheral_blood","Fragment_antigen-binding","Single-chain_variable_fragment","Adalimumab","Passive_immunity","List_of_monoclonal_antibodies"]}